Membrane Transporters/Ion Channels
-
hERG channel activator
NS-1643是一种人类以太相关基因(hERG)KV11.1通道激活剂(EC50 = 10.5 uM)。
了解更多
-
Potassium channel activator
NS1619是Bkca开启剂或大电导Ca2+激活的钾(BKCa,KCa1.1)通道激活剂。
了解更多
-
Doxapram能抑制TASK-1,TASK-3,TASK-1/TASK-3异二聚体通道功能,EC50分别为410 nM,37μM,9μM。Doxapram是一种呼吸刺激剂。静脉注射多沙普兰可刺激潮气量和呼吸频率的增加。
了解更多
-
K+ Channel 抑制剂
K+ Channel inhibitor,Kv1.5(IKur)的二氢吡唑并嘧啶抑制剂的合成基础。
了解更多
-
Potassium channel blocker
Cesium chloride是钾通道阻滞剂。抑制起搏器电流(If)和超极化激活的阳离子电流(Ih)。通过灭活GSK-3β来防止血清和钾缺乏的小脑颗粒神经元中caspase-3的激活和神经元凋亡。
了解更多
-
potassium channel activator
SKA-31是KCa2和KCa3.1钙激活钾通道的激活剂。
了解更多
-
Potassium channel blocker
Dalfampridine is a potassium channel blocker used to help multiple sclerosis patients walk.
了解更多
-
Kv3 potassium channel modulator
AUT1 is a Kv3 potassium channel modulator with pEC50s of 5.33 and 5.31 for human recombinant Kv3.1b and Kv3.2a, respectively, exhibits 10-fold lower potency at human recombinant Kv3.3 channel (pEC50, 4.5).
了解更多
-
Kir7.1 potassium channels blocker
ML418 is a selective, sub-micromolar pore blocker of Kir7.1 potassium channels. The inward rectifier potassium (Kir) channel Kir7.1 (KCNJ13) is a key regulator of melanocortin signaling in the brain, electrolyte homeostasis in the eye, and uterine muscle contractility during pregnancy.
了解更多
-
K+ (KATP) channel activator
Y-26763 is a K+ channel opener and active metabolite of Y-27152. Y-26763 is an ATP-sensitive K+ (KATP) channel activator.
了解更多
-
IKs blocker
JNJ 303 is a potent IKs blocker with an IC50 value of 64 nM.
了解更多
-
HERG activator
RPR-260243 is a novel activator of HERG; modifies HERG currents inhibited by dofetilide (IC50 = 58 nM); little effect on HERG current amplitude and no significant effects on steady-state activation parameters or on channel inactivation processes.
了解更多
-
ROMK inhibitor
MK-7145 is a ROMK inhibitor, with an IC50 of 0.045 μM.
了解更多
-
Ivermectin是一种广谱抗寄生虫阿维菌素药物。
了解更多
-
CaCC blocker
Talniflumate是一种钙激活的氯离子通道(CaCC)(hCLCA1/mCLCA3)阻滞剂;在细胞培养和动物模型中减少粘蛋白的合成和释放。
了解更多
-
CaCCs 抑制剂
CaCCinh-A01抑制人支气管和肠道细胞中的CaCC电流。还抑制TMEM16A通道(表达TMEM16A的FRT细胞中IC50 = 2.1 uM)。
了解更多
-
TMEM16A 抑制剂
T16Ainh-A01是一种选择性TMEM16A钙激活的氯离子通道抑制剂,可强烈抑制唾液腺细胞中的氯离子电流。
了解更多
-
CaCC activator
Eact激活钙激活的氯离子通道(CaCC)TMEM16A CaCC。
了解更多
-
chloride channel blocker
NPPB是一种氯离子通道阻滞剂(IC50 = 80 nM),也被确定为GPR35激动剂。
了解更多
-
SGLT2 抑制剂
Dapagliflozin (BMS512148)抑制钠-葡萄糖转运蛋白(SGLT2)的亚型2,后者负责肾脏中至少90%的葡萄糖重吸收。
了解更多
- David Papadopoli, .et al. Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozin, Neoplasia, 2021, Apr;23(4):391-399 PMID: 33784591
- Neil Tanday, .et al. Dapagliflozin exerts positive effects on beta cells, decreases glucagon and does not alter beta- to alpha-cell transdifferentiation in mouse models of diabetes and insulin resistance, Biochem Pharmacol, 2020, Jul;177:114009 PMID: 32360307
- Subramaniam M, .et al. Comparison of Intestinal Glucose Flux and Electrogenic Current Demonstrates Two Absorptive Pathways in Pig and One in Nile Tilapia and Rainbow Trout, Am J Physiol Regul Integr Comp Physiol, 2019, Nov 20 PMID: 31746628
- Marina Subramaniam, .et al. Sigmoidal kinetics define porcine intestinal segregation of electrogenic monosaccharide transport systems as having multiple transporter population involvement, Physiol Rep, 2019, May; 7(9): e14090 PMID: 31062524
- Angelopoulou A, .et al. Magnetic Nanoparticles for the Delivery of Dapagliflozin to Hypoxic Tumors: Physicochemical Characterization and Cell Studies, AAPS PharmSciTech, 2018, Feb;19(2):621-633 PMID: 8924948
-
SGLT2 抑制剂
canagliflozin是2型亚钠葡萄糖转运蛋白(SGLT2)的抑制剂,作用于hSGLT2,无细胞试验中IC50为2.2 nM,比作用于hSGLT1选择性高413倍。
了解更多
- David Papadopoli, .et al. Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozin, Neoplasia, 2021, Apr;23(4):391-399 PMID: 33784591
- Angelopoulou A, .et al. Canagliflozin-loaded magnetic nanoparticles as potential treatment of hypoxic tumors in combination with radiotherapy, Nanomedicine, 2018, Oct;13(19):2435-2454 PMID: 30311542
-
SGLT2 抑制剂
EGT1442是有效的选择性SGLT2抑制剂。
了解更多
-
Empagliflozin是一种有效的选择性葡萄糖钠共转运蛋白-2抑制剂,目前正在开发中,用于治疗2型糖尿病。
了解更多
- Yu-Jung Heo, .et al. Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway, Biomedicines, 2022, Apr 29;10(5):1032 PMID: 35625768
- Nami Lee, .et al. Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF- κB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways, J Immunol Res, 2021, Jun 2;2021:9944880 PMID: 34124273
- CN Koyani, .et al. Empagliflozin Protects Heart From Inflammation and Energy Depletion via AMPK Activation, Pharmacol Res, 2020, May 17;158:104870 PMID: 32434052
-
SGLT 抑制剂?
LX4211是双重SGLT1/SGLT2抑制剂。
了解更多
-
SGLT2 抑制剂
Tofogliflozin是亚型2钠葡萄糖转运蛋白(SGLT2)的抑制剂,可引起肾脏中至少90%的葡萄糖重吸收。
了解更多
-
SGLT2 抑制剂
Remogliflozin抑制钠葡萄糖转运蛋白(SGLT2),后者负责肾脏中的葡萄糖重吸收。
了解更多
-
SGLT2 抑制剂
Ipragliflozin是一种高效的选择性SGLT2抑制剂,IC50为2.8 nM。SGLT1/3/4/5/6的效力很小且没有效力。
了解更多
-
SGLT2 抑制剂
Luseogliflozin是由Taisho Pharmaceutical开发的一种口服活性第二代钠葡萄糖共转运蛋白2(SGLT2)抑制剂,用于治疗2型糖尿病(T2DM)患者。
了解更多
-
Na+-glucose transporter 抑制剂
T-1095是Na+-葡萄糖共转运蛋白(SGLTs)的有效和选择性抑制剂。
了解更多
-
SGLT2 抑制剂
Canagliflozin hemihydrate是半水形式的卡格列嗪,是一种SGLT2抑制剂,在无细胞检测中hSGLT2的IC50为2.2 nM,其选择性比hSGLT1高413倍。
了解更多
-
SGLT inhibitor
Ertugliflozin pidolate belongs to the class of potent and selective inhibitors of the sodium-dependent glucose cotransporters (SGLT), more specifically the type 2 which is responsible for about 90% of the glucose reabsorption from glomerulus.
了解更多
-
SGLT1 抑制剂
SGL5213 is a potent, oral active and low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor, with IC50 values of 29 nM and 20 nM for hSGLT1 and hSGLT2, respectively.
了解更多
-
SGLT2 抑制剂
Dapagliflozin impurity is an enantiomer of Dapagliflozin which is a sodium-glucose transporter 2 inhibitor.
了解更多
-
SGLT1/SGLT2 抑制剂
Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor.
了解更多
-
MCT1 inhibitor
BAY-8002 is a potent, selective, orally active inhibitor of monocarboxylate transporter 1 (MCT1), with an IC50 of 85 nM in the MCT1-expressing DLD-1 cells, displays excellent selectivity against MCT4. Anti-tumor activity.
了解更多
-
MCT1 and MCT2 抑制剂
AR-C155858是单羧酸转运蛋白mct1和mct2的有效抑制剂,它们与涉及跨膜螺旋7-10的细胞内位点结合。
了解更多
- Charlotte Petersen, .et al. MCT1 and MCT4 Expression and Lactate Flux Activity Increase During White and Brown Adipogenesis and Impact Adipocyte Metabolism, Sci Rep, 2017, 7: 13101 PMID: 29026134
- Kong SC, .et al. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells, Pancreas, 2016, Aug;45(7):1036-47 PMID: 26765963
- Anne Poder, .et al. Roles of acid-extruding ion transporters in regulation of breast cancer cell growth in a 3-dimensional microenvironment, Mol Cancer, 2016, 15: 45 PMID: 27266704
- Eumorphia G. Konstantakou, .et al. 3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants, Mol Cancer, 2015, 14: 135 PMID: 26198749
- Álvarez Z, .et al. Neurogenesis and vascularization of the damaged brain using a lactate-releasing biomimetic scaffold., Biomaterials., 2014, 35(17):4769-81 PMID: 24636215
- Álvarez Z, .et al. Neuronal Progenitor Maintenance Requires Lactate Metabolism and PEPCK-M-Directed Cataplerosis., Cereb Cortex., 2014, 26(3):1046-58 PMID: 25452568
-
MCT 抑制剂
CHC是单羧酸转运(MCT)抑制剂。在神经胶质瘤中具有抗肿瘤和抗血管生成活性;降低U251细胞的糖酵解代谢,迁移和侵袭。
了解更多
-
MCT1 抑制剂
AZD-3965(AZD3965)是具有1.6 nM结合亲和力的单羧酸盐转运蛋白1(MCT1)的选择性抑制剂,是MCT2的6倍选择性,在10μM时不抑制MCT4。
了解更多
- Lu Gao, .et al. Trophoblast-derived Lactic Acid Orchestrates Decidual Macrophage Differentiation via SRC/LDHA Signaling in Early Pregnancy, Int J Biol Sci, 2022, Jan 1;18(2):599-616 PMID: 35002512
-
MCT1 抑制剂
AR-C117977是一种有效的MCT1抑制剂,可以降低体内和体外的免疫应答,维持长期移植物存活,并诱导操作耐受性。
了解更多
-
MCT 抑制剂
7ACC2是一种新型有效的MCT抑制剂,IC50为11 nM,可抑制[14C]-乳酸盐涌入。针对癌细胞中乳酸转运的新型抗肿瘤治疗。
了解更多
-
MCT 抑制剂?
7ACC1在富含乳酸的肿瘤微环境中选择性干扰乳酸通量;在表达MCT1和MCT4转运蛋白的肿瘤细胞中,乳酸抑制乳酸盐流入,但不流出。
了解更多
- Daniel Gundel, .et al. Preclinical Evaluation of [18F]FACH in Healthy Mice and Piglets: An 18F-Labeled Ligand for Imaging of Monocarboxylate Transporters with PET, Int J Mol Sci, 2021, Feb; 22(4): 1645 PMID: 33562048
-
MCT 抑制剂
UK 5099是质膜单羧酸盐转运蛋白(MCT)和线粒体丙酮酸载体(MPC)的有效抑制剂。抑制丙酮酸依赖性的氧气消耗,IC50为50 nM。
了解更多
-
AMPA 拮抗剂
Tezampanel是AMPA和离子型谷氨酸受体的海藻酸盐家族的拮抗剂,对海藻酸盐受体的GluR5亚型具有选择性。
了解更多
-
AMPA 拮抗剂
YM90K hydrochloride是一种选择性AMPA受体拮抗剂,在局部缺血后给药后,可延迟整体缺血模型中的神经元死亡和局部缺血模型中的脑梗塞。
了解更多
-
AMPA/kainate receptor 拮抗剂
Talampanel是AMPA受体的非竞争性拮抗剂,具有抗癫痫活性。
了解更多
-
AMPA 拮抗剂
CP 465022 hydrochloride是一种选择性的非竞争性AMPA拮抗剂,在大鼠皮质神经元中的IC50为25 nM,显示出有效的抗惊厥活性。
了解更多
-
AMPAR negative modulator
JNJ-61432059 is an oral active and selective negative modulator of AMPAR associated with trans-membrane AMPAR regulatory protein (TARP) γ-8, with a pIC50 of 9.7 for GluA1/γ-8.
了解更多
-
AMPA receptor antagonist
SYM 2206 is a novel, potent, non-competitive AMPA receptor antagonist.
了解更多
-
AMPA receptor positive allosteric modulator
PF-4778574 is a potent AMPA receptor positive allosteric modulator (PAM) that has been shown to enhance cognition in animal models.
了解更多
-
AMPA/kainate antagonist
Fanapanel (ZK200775) is a highly selective AMPA/kainate antagonist with little activity against NMDA; have Ki values of 3.2 nM, 100 nM, and 8.5 μM against quisqualate, kainate, and NMDA, respectively.
了解更多